Drug Comparison

Semaglutide (Wegovy) vs. Liraglutide (Victoza): A Patient Comparison

Semaglutide (Wegovy) and Liraglutide (Victoza) are both injectable medications that mimic a natural hormone to help manage health conditions. While they belong to the same drug class, they have different primary uses and dosing schedules, leading patients to often compare their benefits.

Side-by-Side Comparison

CategorySEMAGLUTIDELIRAGLUTIDE
Drug ClassGLP-1 Receptor Agonist (Semaglutide)GLP-1 Receptor Agonist (Liraglutide)
Primary Use (as per provided info)Weight loss (adults and children 12+) and cardiovascular risk reduction in adults with established CV diseaseType 2 diabetes management (adults and children 10+) and cardiovascular risk reduction in adults with type 2 diabetes
Dosing FrequencyTypically once weeklyTypically once daily
Cardiovascular BenefitReduces risk of major adverse cardiovascular events in adults with established CV diseaseReduces risk of major adverse cardiovascular events in adults with type 2 diabetes
Age Approved ForAdults and children aged 12 and olderAdults and children aged 10 and older
When to ChooseA doctor might prefer Semaglutide (Wegovy) if the primary goal is weight loss, especially for adults or children aged 12 and older. It may also be chosen for adults with established cardiovascular disease to reduce heart risks, offering the convenience of once-weekly dosing.A doctor might prefer Liraglutide (Victoza) if the main focus is improving blood sugar control in adults or children aged 10 and older with type 2 diabetes. It also offers cardiovascular benefits for adults with type 2 diabetes, despite requiring daily injections.
Side EffectsBoth medications share similar potential side effects, including gastrointestinal issues like nausea, vomiting, diarrhea, and constipation. Both carry warnings about acute pancreatitis and acute gallbladder issues, so patients should report any severe abdominal pain promptly.
CostNeither Semaglutide nor Liraglutide are currently available as generics, meaning both are brand-name medications. This typically makes them more expensive, and cost can vary significantly based on insurance coverage and pharmacy.

Bottom Line

Semaglutide (Wegovy) and Liraglutide (Victoza) are effective GLP-1 agonists, but their primary indications differ. Wegovy is primarily for weight loss with cardiovascular benefits, while Victoza is for type 2 diabetes management with cardiovascular benefits. Your doctor will help determine which medication is best suited for your specific health needs and goals.

SEMAGLUTIDE Overview

Wegovy is a prescription medication that belongs to a class of drugs called GLP-1 receptor agonists. It is used alongside a reduced-calorie diet and increased physical activity to help adults and children aged 12 and older lose weight and keep it off, especially for those with obesity or who are overweight with related health conditions. Wegovy also helps reduce the risk of serious heart problems like heart attack or stroke in adults with existing heart disease and obesity or overweight.

Full SEMAGLUTIDE guide →

LIRAGLUTIDE Overview

Liraglutide (Victoza) is a type of medicine that mimics a natural hormone in your body. It is prescribed to help adults and children aged 10 and older with type 2 diabetes manage their blood sugar levels, and it can also lower the risk of serious heart problems like heart attack or stroke in adults with type 2 diabetes and existing heart disease. It works by helping your body release insulin when needed and reducing the amount of sugar your liver makes.

Full LIRAGLUTIDE guide →

Zova.Health

AI Nutrition for GLP-1 Users

Protect your muscle mass on GLP-1 medications

GLP-1 medications like Ozempic and Mounjaro accelerate weight loss — but up to 40% of that loss can be lean muscle. Zova.Health uses AI to optimize your protein intake, leucine targets, and injection-day meals to preserve the muscle that matters.

Muscle preservation trackingLeucine optimizationInjection-day meal plans
Join the Waitlist

Free · No credit card required

Why it matters:

Clinical studies show GLP-1 users who optimize protein intake preserve 2–3× more lean muscle during weight loss.

Medical Disclaimer

The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.